- Home
- RGNX vs HIFS Comparison
RGNX vs HIFS Comparison
Compare RGNX & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGNX | HIFS |
|---|---|---|
| Founded | 2008 | 1834 |
| Country | United States | United States |
| Employees | N/A | 97 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.5M | 679.7M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | RGNX | HIFS |
|---|---|---|
| Price | $7.45 | $296.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $28.75 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 30.8K |
| Earning Date | 05-05-2026 | 04-17-2026 |
| Dividend Yield | N/A | ★ 0.89% |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | $51.21 | N/A |
| Revenue Next Year | $19.08 | N/A |
| P/E Ratio | ★ N/A | $12.63 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.46 | $248.53 |
| 52 Week High | $16.19 | $338.00 |
Technical Indicators
Market Signals| Indicator | RGNX | HIFS |
|---|---|---|
| Relative Strength Index (RSI) | 34.34 | 44.35 |
| Support Level | $5.67 | $279.35 |
| Resistance Level | $11.43 | $304.42 |
| Average True Range (ATR) | 0.45 | 8.77 |
| MACD | -0.06 | -1.41 |
| Stochastic Oscillator | 12.07 | 14.41 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a Massachusetts-chartered savings bank headquartered in Hingham, Massachusetts. The bank is principally engaged in the business of commercial and residential real estate mortgage lending, funded by a mix of retail and commercial deposits, wholesale deposits and borrowings. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending products are residential and commercial mortgage loans secured by properties in eastern Massachusetts. The bank also lends to commercial and residential real estate borrowers and services deposits for customers in the greater Washington, D.C. metropolitan area (WMA) and in the San Francisco Bay Area.